Girl in a jacket Germany

Rehabilitation and Medical Centers

Olga hospital

Specialities:

A private hospital that offers addiction treatment, amongst other medical services.

Contact Address:

Klinikum Stuttgart - Olga Hospital (OH)
Bismarck Strasse 8, 70176 Stuttgart
Phone: + 49278-04 0711
E-mail: info@klinikum-stuttgart.de
Website:http://www.klinikum-stuttgart.de/ueber-uns/struktur/standorte/olgahospital.html

Description:

The Olga hospital - called by the Stuttgart lovingly "Olgäle" - is one of Germany's longest and largest hospitals for children and adolescents with 280 planned beds and day hospital treatment courses.

National Narcotics Control Authorities

Name:

DBDD - German Monitoring Centre for Drugs and Drug Addiction

Contact/ address:

Parzivalstr. 25, Munich, 80804
Tel. +4989/36080441
Fax +4989/36080449
E-mail: gruebl@ift.de

Website:http://www.dbdd.de/

After establishment of the European Monitoring Centre for Drugs and Drug Addiction in 1993, the German Ministry for Health, nominated the Federal Centre for Health Education (Federal Centre for Health Education, BZgA, Cologne), the German Centre for Addiction Issues (German Centre for Addiction Issues DHS, Hamm) and the IFT Institute for Therapy Research to act Jointly as the German national focal point within the Reitox network of the EMCDDA.

Together, the three institutions form the German Monitoring Centre for Drugs and Drug Addiction (DBDD) with the IFT as the responsible overall management institution of the NFP.

National Narcotics Control Strategies and Security Plans

Name:

Germay Drug Strategy 2003

Type:

Preventative

Published Authority:

Ministry of Public Administration and Justice

Date:

2003

Internet Link:

http://www.emcdda.europa.eu/countries/national-drug-strategies/germany

Publisher website:

http://www.emcdda.europa.eu

Narcotics control regulations and laws

Name:

Germany,The Misuse of Drugs Acts,1929, 1961

Published Authority:

Ministry of Justice

Date:

1929

Internet link:

http://www.emcdda.europa.eu/html.cfm/index5174EN.html?pluginMethod=eldd.countryprofiles&country=DE

Publisher website:

http://www.emcdda.europa.eu

Facts and stats

  • Estimate of the expenditure of the public sector through the use of illegal drugs in Germany (Mostardt et al., 2010).
  • Epidemiological Survey on Addictions - ESA (Kraus & Pabst 2010) (Kraus et al, 2010; Pabst et al, 2010.).
  • The school remains closed environment of the most important setting for universal drug prevention, while family-oriented and community-based interventions are less available.
  • The most recent estimate of problem drug use, including opiates, cocaine and amphetamine use, treatment is based on data for 2010. According to the data, the prevalence is estimated at between 200 402 and 237 977 (3.7-4.4 per 1000 inhabitants aged 15-64).
  • Up to 2012 the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), defined as injecting drug use problem-drug use (IDU) or long duration / regular drug use of opiates, cocaine and / or amphetamines. Ecstasy and cannabis were not included in this category. Details are available here.

Governmental / Non-governmental Associations

DBDD - German Monitoring Centre for Drugs and Drug Addiction

Type:

Governmental

Address & Contact:

DBDD - German Monitoring Centre for Drugs and Drug Addiction,
Parzivalstr. 25, Munich, 80804
Tel. +4989/36080441
Fax +4989/36080449
E-mail: gruebl@ift.de
Website:http://www.dbdd.de/

After establishment of the European Monitoring Centre for Drugs and Drug Addiction in 1993, the German Ministry for Health, nominated the Federal Centre for Health Education (Federal Centre for Health Education, BZgA, Cologne), the German Centre for Addiction Issues (German Centre for Addiction Issues DHS, Hamm) and the IFT Institute for Therapy Research to act Jointly as the German national focal point within the Reitox network of the EMCDDA.

Together, the three institutions form the German Monitoring Centre for Drugs and Drug Addiction (DBDD) with the IFT as the responsible overall management institution of the NFP.